Thrombin generation in hemorrhage control and vascular occlusion.
作者信息
Mann Kenneth G
机构信息
Department of Biochemistry, Colchester Research Facility Room 235, University of Vermont, Colchester, VT 05446, USA.
出版信息
Circulation. 2011 Jul 12;124(2):225-35. doi: 10.1161/CIRCULATIONAHA.110.952648.
Abstract
摘要
相似文献
1
Thrombin generation in hemorrhage control and vascular occlusion.
Circulation. 2011 Jul 12;124(2):225-35. doi: 10.1161/CIRCULATIONAHA.110.952648.
2
Thrombin Generation Assays (TGAs).
Methods Mol Biol. 2017;1646:515-522. doi: 10.1007/978-1-4939-7196-1_37.
3
Mechanism of action of recombinant activated factor VII: an update.
Semin Hematol. 2006 Jan;43(1 Suppl 1):S105-7. doi: 10.1053/j.seminhematol.2005.11.025.
4
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.
JCI Insight. 2018 Mar 22;3(6):98459. doi: 10.1172/jci.insight.98459.
5
[Thrombin generation assays and their clinical application].
Orv Hetil. 2014 Jun 1;155(22):851-7. doi: 10.1556/OH.2014.29899.
6
Coagulation Profile after Spontaneous Intracerebral Hemorrhage: A Cohort Study.
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):2951-2961. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.022. Epub 2018 Jul 30.
7
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Blood. 2015 Jul 16;126(3):397-405. doi: 10.1182/blood-2014-12-616565. Epub 2015 Apr 24.
8
Blood coagulation: hemostasis and thrombin regulation.
Anesth Analg. 2009 May;108(5):1433-46. doi: 10.1213/ane.0b013e31819bcc9c.
9
[Coagulation and fibrinolytic activity of lymph in various pathological conditions (review of own and literature data)].
Patol Fiziol Eksp Ter. 2013 Jan-Mar(1):99-108.
10
Thrombin and protease-activated receptors (PARs) in atherothrombosis.
Thromb Haemost. 2008 Feb;99(2):305-15. doi: 10.1160/TH07-08-0481.
引用本文的文献
1
Protofibril packing density of individual fibers alters fibrinolysis.
Res Pract Thromb Haemost. 2025 Feb 28;9(2):102708. doi: 10.1016/j.rpth.2025.102708. eCollection 2025 Feb.
2
Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review.
Medicina (Kaunas). 2024 Jul 30;60(8):1240. doi: 10.3390/medicina60081240.
3
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102351. doi: 10.1016/j.rpth.2024.102351. eCollection 2024 Feb.
4
An intelligent DNA nanodevice for precision thrombolysis.
Nat Mater. 2024 Jun;23(6):854-862. doi: 10.1038/s41563-024-01826-y. Epub 2024 Mar 6.
5
Statins Effects on Blood Clotting: A Review.
Cells. 2023 Nov 27;12(23):2719. doi: 10.3390/cells12232719.
6
P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions.
Thromb Haemost. 2023 Feb;123(2):231-244. doi: 10.1055/s-0042-1758655. Epub 2023 Jan 11.
7
Comparative sequence analysis of vitamin K-dependent coagulation factors.
J Thromb Haemost. 2022 Dec;20(12):2837-2849. doi: 10.1111/jth.15897. Epub 2022 Oct 11.
8
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics.
Int J Mol Sci. 2021 Feb 20;22(4):2119. doi: 10.3390/ijms22042119.
9
Self-regulated hirudin delivery for anticoagulant therapy.
Sci Adv. 2020 Oct 9;6(41). doi: 10.1126/sciadv.abc0382. Print 2020 Oct.
10
Intelligent classification of platelet aggregates by agonist type.
Elife. 2020 May 12;9:e52938. doi: 10.7554/eLife.52938.
本文引用的文献
1
Dilutional control of prothrombin activation at physiologically relevant shear rates.
Biophys J. 2011 Feb 2;100(3):765-773. doi: 10.1016/j.bpj.2010.12.3720.
2
The molecular origins of the mechanical properties of fibrin.
Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009.
3
Cellular regulation of blood coagulation: a model for venous stasis.
Blood. 2010 Dec 23;116(26):6082-91. doi: 10.1182/blood-2010-01-266395. Epub 2010 Sep 23.
4
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.
N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475.
5
Eptifibatide: The evidence for its role in the management of acute coronary syndromes.
Core Evid. 2010 Jun 15;4:49-65. doi: 10.2147/ce.s6008.
6
Biomechanics in hemostasis and thrombosis.
J Thromb Haemost. 2010 May;8(5):1027-9. doi: 10.1111/j.1538-7836.2010.03808.x. Epub 2010 Feb 11.
7
The mechanical properties of single fibrin fibers.
J Thromb Haemost. 2010 May;8(5):1030-6. doi: 10.1111/j.1538-7836.2010.03745.x. Epub 2010 Jan 17.
8
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.
J Thromb Haemost. 2009 May;7(5):871-8. doi: 10.1111/j.1538-7836.2009.03323.x. Epub 2009 Feb 18.
9
Discordant fibrin formation in hemophilia.
J Thromb Haemost. 2009 May;7(5):825-32. doi: 10.1111/j.1538-7836.2009.03306.x. Epub 2009 Jan 28.
10
Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation.
Atherosclerosis. 2009 Jun;204(2):636-41. doi: 10.1016/j.atherosclerosis.2008.10.039. Epub 2008 Nov 12.
Zotero 插件